scispace - formally typeset
M

Maria Mota

Researcher at University of Medicine and Pharmacy of Craiova

Publications -  40
Citations -  797

Maria Mota is an academic researcher from University of Medicine and Pharmacy of Craiova. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 9, co-authored 35 publications receiving 725 citations.

Papers
More filters
Journal ArticleDOI

New susceptibility loci associated with kidney disease in type 1 diabetes.

Niina Sandholm, +105 more
- 20 Sep 2012 - 
TL;DR: A meta-analysis of genome-wide association studies of T1D DN revealed association of two SNPs with ESRD in the AFF3 gene and an intergenic SNP on chromosome 15q26 between the genes RGMA and MCTP2, which represent new signals in the pathogenesis of DN.
Journal Article

Erectile dysfunction in diabetes mellitus.

TL;DR: The results plead for a holistic approach of the diabetic patient, irrespective of age, in order to detect and to treat all the risk factors, keeping in mind that the appearance of erectile dysfunction might indicate the presence of occult chronic diabetes complications.
Journal ArticleDOI

Prevalence of diabetes mellitus and prediabetes in the adult Romanian population: PREDATORR study.

TL;DR: The PREDATORR (PREvalence of DiAbeTes mellitus, predi diabetes, overweight, Obesity, dyslipidemia, hyperuricemia and chronic kidney disease in Romania) study is the first national study analyzing the prevalence of diabetes mellitus and prediabetes, and their association with cardiometabolic, sociodemographic, and lifestyle risk factors in the Romanian population aged 20–79 years.
Journal ArticleDOI

35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999.

Arne Melander, +4778 more
- 01 Aug 1999 - 
Journal ArticleDOI

Association of SGK1 gene polymorphisms with type 2 diabetes.

TL;DR: The observations support the view that SGK-1 may participate in the pathogenesis of metabolic syndrome and the impact of this risk haplotype on blood pressure.